Evidence-based·Updated November 16, 2026·How we grade evidence

Clarithromycin

MedicationMacrolide antibiotic (prescription)

Clarithromycin prevented MAC infection in people with advanced AIDS (6% versus 16% on placebo) and reduced deaths, and it is part of some H. pylori regimens, although a 7-day clarithromycin triple therapy cleared only 55% of infections in a large European trial and US guidance now prefers other first choices. A 2-week course in people with stable coronary heart disease increased cardiovascular deaths. Red yeast rice is the main supplement issue.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults and children with a bacterial infection their prescriber expects clarithromycin to treat, people with advanced HIV who need MAC treatment or prevention, and selected H. pylori regimens

Common dosing range

Set by your prescriber. The tablet label gives 250 to 500 mg every 12 hours for 7 to 14 days for most adult infections, 500 mg every 12 hours for MAC, and 500 mg every 8 to 12 hours for 10 to 14 days in H. pylori combinations; children 15 mg/kg a day in two doses

When to expect effects

Courses of 7 to 14 days for most infections; MAC prevention is continued long term

Watch out for

Dangerous interactions through CYP3A4: colchicine (fatal cases), simvastatin and lovastatin (contraindicated), some calcium channel blockers, warfarin and others. Also QT prolongation, liver injury, C. difficile diarrhea, worse myasthenia gravis, and higher long-term mortality seen in people with heart disease

What is it

Clarithromycin is a prescription macrolide antibiotic sold as generic tablets, extended-release tablets and an oral suspension (the original brand was Biaxin). The label approves it for mild to moderate bacterial infections, including some chest, sinus, throat, skin and ear infections, for treating and preventing Mycobacterium avium complex (MAC) infection in people with advanced HIV, and, combined with other drugs, for clearing Helicobacter pylori to reduce the return of duodenal ulcers. The label calls it a strong blocker of the CYP3A4 enzyme, which is why it has so many serious drug interactions.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

Your prescriber has diagnosed a bacterial infection that clarithromycin is expected to treat, or you need MAC treatment or prevention with advanced HIV
Your prescriber chooses a clarithromycin regimen for H. pylori, ideally when the strain is known to be susceptible
Your pharmacist has checked your full medicine and supplement list for CYP3A4 interactions

Probably skip if…

You have had an allergic reaction to clarithromycin, erythromycin or any macrolide, or cholestatic jaundice or liver problems with past clarithromycin use: the label lists these as contraindications
You take cisapride, pimozide, lomitapide, lovastatin, simvastatin, ergotamine, dihydroergotamine or lurasidone, or colchicine with kidney or liver impairment: the label contraindicates these combinations
You have known QT prolongation, a history of torsades de pointes, uncorrected low potassium or magnesium, or significant slow heart rate, or take other drugs known to prolong the QT interval or class IA or III antiarrhythmics: the label says to avoid it
The illness is viral, such as a cold: antibiotics do not treat viruses

Evidence at a glance

preventing MAC infection in advanced AIDS

Good Evidence
Effect
About 69% fewer MAC infections and 25% lower risk of death over about 10 months
Best fit
People with advanced HIV and very low CD4 counts
Time
Benefit seen over months of daily use

Helicobacter pylori eradication (triple therapy)

Good Evidence
Effect
About 55% eradication with 7-day triple therapy in one European trial
Best fit
Adults with H. pylori known or likely to be clarithromycin-susceptible
Time
Cure confirmed by breath test 4 to 8 weeks after treatment

stable coronary heart disease (off-label, not effective)

Good Evidence
Effect
No benefit; about 27% higher risk of death over 3 years
Best fit
Not applicable: no group with heart disease benefited
Time
Harm seen over 1 to 10 years after a 2-week course

Evidence for 3 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

preventing MAC infection in advanced AIDS

Disease adjunct
Good Evidence

A double-blind trial in the US and Europe randomly assigned 667 people with AIDS and CD4 counts of 100 or less to clarithromycin 500 mg twice daily or placebo. It was stopped after the first interim analysis: MAC infection developed in 6% on clarithromycin versus 16% on placebo (adjusted hazard ratio 0.31). Over about 10 months, 32% versus 41% died (hazard ratio 0.75). In 11 of the 19 people who still developed MAC on clarithromycin, the bacteria were resistant to it. Taste changes were more common on clarithromycin. The trial was done in the 1990s, before modern HIV treatment.

Effect size
About 69% fewer MAC infections and 25% lower risk of death over about 10 months
Time to effect
Benefit seen over months of daily use
Best fit
People with advanced HIV and very low CD4 counts
Less likely
People whose immune system has recovered on HIV treatment, who were not studied here

Bottom line: Clarithromycin prevented MAC infection and lowered deaths in people with advanced AIDS.

Helicobacter pylori eradication (triple therapy)

Disease adjunct
Good Evidence

Clarithromycin is approved with amoxicillin and a proton pump inhibitor to clear H. pylori, but resistance has cut its success. In a European trial of 440 adults, 7 days of omeprazole, amoxicillin and clarithromycin cleared the infection in 55% (123 of 222), versus 80% with 10 days of bismuth quadruple therapy (intention to treat). The 2024 American College of Gastroenterology guideline prefers 14 days of bismuth quadruple therapy for first treatment when antibiotic susceptibility is unknown, and says clarithromycin salvage regimens should be used only when susceptibility is confirmed.

Effect size
About 55% eradication with 7-day triple therapy in one European trial
Time to effect
Cure confirmed by breath test 4 to 8 weeks after treatment
Best fit
Adults with H. pylori known or likely to be clarithromycin-susceptible
Less likely
People with known or suspected clarithromycin-resistant strains, where the label says efficacy is reduced

Bottom line: Clarithromycin triple therapy still clears many H. pylori infections, but resistance makes it a weaker first choice than bismuth quadruple therapy.

stable coronary heart disease (off-label, not effective)

No benefit found
Good Evidence

Off-label use: the label says treating coronary artery disease is not an approved use. The CLARICOR trial randomly assigned 4,373 Danish adults with stable coronary heart disease to 2 weeks of clarithromycin 500 mg a day or placebo. Over 3 years it did not reduce the combined rate of death, heart attack or unstable angina (hazard ratio 1.15), and deaths were higher on clarithromycin (hazard ratio 1.27), driven by cardiovascular deaths (1.45). At 10 years, all-cause mortality remained higher (1.10), and the increase was confined to people not taking a statin at entry. The label now warns about higher mortality one year or more after treatment in people with coronary artery disease.

Effect size
No benefit; about 27% higher risk of death over 3 years
Time to effect
Harm seen over 1 to 10 years after a 2-week course
Best fit
Not applicable: no group with heart disease benefited
Less likely
People with stable coronary heart disease, especially those not taking a statin

Bottom line: A short clarithromycin course did not help people with stable coronary heart disease and was followed by more deaths.

How it works

Clarithromycin binds to the 50S subunit of the bacterial ribosome and stops bacteria from making proteins, which halts their growth. Resistance is a growing problem, especially for H. pylori, and the label says clarithromycin regimens should not be used when the strain is known or suspected to be resistant. About half of a 250 mg tablet reaches the blood. Food delays absorption slightly but does not change the total amount, and the label says the tablets can be taken with or without food and with milk. Clarithromycin is a strong CYP3A4 inhibitor, so it raises the blood levels of drugs cleared by that enzyme, such as colchicine, simvastatin, lovastatin and some calcium channel blockers, sometimes to toxic levels. Red yeast rice falls into this group because its main cholesterol-lowering compound, monacolin K, is the same molecule as lovastatin.

How to take it

1. Typical dose
Your prescriber sets the dose. For adults, the tablet label gives 250 to 500 mg every 12 hours for 7 to 14 days depending on the infection; 500 mg every 12 hours for MAC; and, for H. pylori, 500 mg every 12 hours with amoxicillin and lansoprazole for 10 or 14 days, 500 mg every 12 hours with amoxicillin and omeprazole for 10 days, or 500 mg every 8 hours with omeprazole for 14 days. Children receive 15 mg/kg a day in two divided doses for 10 days, or 7.5 mg/kg up to 500 mg every 12 hours for MAC. The label halves the dose in severe kidney impairment (creatinine clearance under 30 mL/min) and adjusts it further with atazanavir or ritonavir.
2. Higher studied dose
1,000 mg and 2,000 mg twice a day were studied for MAC in people with AIDS. The label reports that the higher doses controlled MAC in the blood better only during the first 4 weeks, that 12% on 1,000 mg versus 8% on 500 mg stopped because of side effects, and that one trial had more deaths in the first 12 weeks on 1,000 mg (13 of 51 versus 2 of 53), for unknown reasons. The label uses 500 mg twice a day.
3. Timing
Every 12 hours for most infections, or every 8 hours in one H. pylori regimen.
4. With food
With or without food; the label says the tablets can also be taken with milk.
5. Split dosing
Yes; usually two doses a day, 12 hours apart.
6. How long to try
Usually 7 to 14 days; finish the course your prescriber sets. MAC prevention continues as long as your prescriber advises.

What to track

Diarrhea, especially watery or bloody, during or up to 2 months after the course (contact your prescriber; it can signal C. difficile infection)
Fainting, a racing or irregular heartbeat or dizziness
Yellow skin or eyes, dark urine, itching or stomach tenderness
Muscle pain, weakness or dark urine if you take a statin or red yeast rice
Bleeding or bruising and your INR if you take warfarin
Low blood sugar if you take diabetes medicines

Bottom line: Your prescriber sets the dose. Food and milk are fine; the important step is checking every other medicine and supplement for interactions before the first dose.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

DiarrheaNausea and vomitingStomach pain or indigestionAltered or metallic tasteHeadache

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the label says clarithromycin is not recommended in pregnancy except when no alternative therapy is appropriate, because it caused malformations in rats and mice at clinically relevant doses; human data are too limited to judge the risk. Breastfeeding: clarithromycin and its active metabolite pass into breast milk at less than 2% of the mother's weight-adjusted dose, and in a small observational study side effects in breastfed infants (rash, diarrhea, poor appetite, sleepiness) were similar to amoxicillin. The label says to weigh the benefits of breastfeeding with the mother's need for the drug. Talk with your prescriber.

Interactions

ColchicineCritical

The label reports life-threatening and fatal interactions, even at recommended doses, because clarithromycin blocks colchicine's clearance. The combination is contraindicated with kidney or liver impairment, and otherwise the colchicine dose must be reduced. Tell your prescriber if you take colchicine for gout or another condition.

Simvastatin and lovastatinCritical

The label contraindicates these statins with clarithromycin because rhabdomyolysis has been reported; if clarithromycin cannot be avoided, the statin must be paused during the course. With atorvastatin the label caps the dose at 20 mg a day. Your prescriber will plan around your statin.

Red yeast riceHigh

Red yeast rice contains monacolin K, which is lovastatin; 12 products tested contained 0.10 to 10.09 mg per capsule. The clarithromycin label contraindicates lovastatin because clarithromycin raises its level and rhabdomyolysis has been reported. Red yeast rice itself has not been studied with clarithromycin. Review it with your prescriber or pharmacist before the course, and report muscle pain, weakness or dark urine.

WarfarinHigh

The label warns of serious bleeding and large rises in INR when clarithromycin is combined with warfarin, and says INR should be checked frequently. Tell whoever manages your warfarin before you start.

St. John's wortHigh

The clarithromycin label lists St. John's wort among reported CYP3A-based interactions and says to use caution. St. John's wort strongly speeds up CYP3A (activity rose 272% in one study), and the label says CYP3A inducers lower clarithromycin levels and could impair its effect, so another antibiotic should be considered. No study has measured clarithromycin levels with the herb. Tell your prescriber before the course if you take it.

ProbioticsLow

Clarithromycin may kill the live bacteria in probiotic products: in lab tests, common probiotic Lactobacillus and Bifidobacterium strains, including GG and Bb12, were all sensitive to erythromycin, a closely related macrolide (clarithromycin itself was not tested). This may make a probiotic less useful but does not weaken the antibiotic. No trial has shown whether spacing the two apart helps or set the best gap; ask your pharmacist about timing.

KefirLow

Kefir's live microbes may be affected by the antibiotic. The dairy calcium issue that affects tetracyclines does not apply here: the clarithromycin label says it can be taken with milk. In a randomized trial of 125 children aged 1 to 5 taking antibiotics, kefir did not prevent antibiotic-associated diarrhea (18% versus 21.9% with placebo). Ask your pharmacist about timing if you drink it.

Documented interactions

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Clarithromycin tablets, extended-release tablets or suspension dispensed on your own prescription
Whether it is the immediate-release or extended-release form, since doses and schedules differ
A pharmacy interaction check that covers statins, colchicine, calcium channel blockers, blood thinners and supplements such as red yeast rice

Be skeptical of…

Leftover or shared antibiotics, or clarithromycin sold without a prescription
Red yeast rice or "natural statin" products presented as safe to take with any antibiotic
Probiotic or kefir products claiming to prevent all antibiotic side effects
Advice to stop the course early once you feel better

Frequently asked questions

Can I take red yeast rice while on clarithromycin?⌄

Review it with your prescriber or pharmacist first. Red yeast rice contains monacolin K, which is lovastatin, and the clarithromycin label contraindicates lovastatin because clarithromycin raises its level and muscle breakdown has been reported. Report any muscle pain, weakness or dark urine.

Can I take clarithromycin with milk or yogurt?⌄

Yes. The label says the tablets can be taken with or without food and with milk. The dairy calcium problem that affects tetracycline and fluoroquinolone antibiotics is not listed for clarithromycin.

Should I take a probiotic during the course?⌄

Clarithromycin may kill bacteria in probiotic products (lab tests used erythromycin, a closely related macrolide). No trial has shown whether spacing the two apart helps or set the best gap. Evidence that they prevent antibiotic side effects is mixed; kefir did not prevent diarrhea in a trial in young children. Ask your pharmacist.

Why does my pharmacist ask about all my other medicines?⌄

Clarithromycin is a strong blocker of the CYP3A4 enzyme, so it can raise other drugs to dangerous levels. The label lists serious reactions with colchicine, some statins, some blood pressure medicines (calcium channel blockers), warfarin and diabetes medicines, among others.

I have heart disease. Is clarithromycin safe for me?⌄

The label warns that one trial found higher mortality one year or more after treatment in people with coronary artery disease, and it also warns about QT prolongation. Your prescriber will weigh this against the benefit for your infection, so make sure they know your heart history.

References by claim

preventing MAC infection in advanced AIDS

Pierce et al., 1996 · PubMed (1996) link

Helicobacter pylori eradication (triple therapy)

Malfertheiner et al., 2011 · PubMed (2011) link

Chey et al., 2024 · PubMed (2024) link

stable coronary heart disease (off-label, not effective)

Jespersen et al., 2006 · PMC (2006) link

Winkel et al., 2015 · PubMed (2015) link

Safety

Clarithromycin tablets USP prescribing information · DailyMed (FDA label) link

Interaction: Red yeast rice

Gordon et al., 2010 · PubMed (2010) link

Lovastatin tablets USP prescribing information · DailyMed (FDA label) link

Interaction: Probiotics

Zhou et al., 2005 · PubMed (2005) link

Interaction: Kefir

Merenstein et al., 2009 · PubMed (2009) link

Interaction: St. John's wort

Huppertz et al., 2018 · PMC (2018) link

Track Clarithromycin with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 16, 2026·Evidence current as of Nov 16, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.